메뉴 건너뛰기




Volumn 54, Issue 5, 2011, Pages 1096-1100

Bioanalytical method development and validation of natamycin in rabbit tears and its application to ocular pharmacokinetic studies

Author keywords

Bioanalytical method; LC MS MS; Natamycin; Ocular pharmacokinetics; Rabbit tear

Indexed keywords

AMMONIUM ACETATE; AMPHOTERICIN B; DYE; LUNA CYANO; METHANOL; NATAMET; NATAMYCIN; UNCLASSIFIED DRUG;

EID: 78751703553     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.11.028     Document Type: Article
Times cited : (26)

References (12)
  • 3
    • 41849095665 scopus 로고    scopus 로고
    • Mycotic keratitis: an overview of diagnosis and therapy
    • Shukla P.K., Kumar M., Keshava G.B.S. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses 2008, 51:183-1999.
    • (2008) Mycoses , vol.51 , pp. 183-1999
    • Shukla, P.K.1    Kumar, M.2    Keshava, G.B.S.3
  • 4
    • 52449132114 scopus 로고    scopus 로고
    • Development of effective ocular preparations of antifungal agents
    • Kaur I.P., Rana C., Singh H. Development of effective ocular preparations of antifungal agents. J. Ocul. Pharmacol. Ther. 2008, 24:481-493.
    • (2008) J. Ocul. Pharmacol. Ther. , vol.24 , pp. 481-493
    • Kaur, I.P.1    Rana, C.2    Singh, H.3
  • 5
    • 53649090786 scopus 로고    scopus 로고
    • In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder
    • Lalitha P., Vijaykumar R., Prajna N.V., Fothergill A.W. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. J. Clin. Microbiol. 2008, 46:3477-3478.
    • (2008) J. Clin. Microbiol. , vol.46 , pp. 3477-3478
    • Lalitha, P.1    Vijaykumar, R.2    Prajna, N.V.3    Fothergill, A.W.4
  • 6
    • 0346327201 scopus 로고    scopus 로고
    • Fungal infections of the cornea
    • Thomas P.A. Fungal infections of the cornea. Eye 2003, 17:852-862.
    • (2003) Eye , vol.17 , pp. 852-862
    • Thomas, P.A.1
  • 7
    • 0035014441 scopus 로고    scopus 로고
    • Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method
    • Lee J.W., Petersen M.E., Lin P., Dressler D., Bekersky I. Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method. Ther. Drug Monit. 2001, 23:268-276.
    • (2001) Ther. Drug Monit. , vol.23 , pp. 268-276
    • Lee, J.W.1    Petersen, M.E.2    Lin, P.3    Dressler, D.4    Bekersky, I.5
  • 8
    • 74049100558 scopus 로고    scopus 로고
    • Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques
    • Deshpande N.M., Gangrade M.G., Kekare M.B., Vaidya V.V. Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878:315-326.
    • (2010) J. Chromatogr. B Anal. Technol. Biomed. Life Sci. , vol.878 , pp. 315-326
    • Deshpande, N.M.1    Gangrade, M.G.2    Kekare, M.B.3    Vaidya, V.V.4
  • 9
    • 43049102370 scopus 로고    scopus 로고
    • Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry
    • Arnold D.R., Granvil C.P., Ward K.W., Proksch J.W. Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 867:105-110.
    • (2008) J. Chromatogr. B Anal. Technol. Biomed. Life Sci. , vol.867 , pp. 105-110
    • Arnold, D.R.1    Granvil, C.P.2    Ward, K.W.3    Proksch, J.W.4
  • 10
    • 78751704619 scopus 로고    scopus 로고
    • Guidance for Industry, Bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration center for Drug Evaluation And Research Center (CDER), Center for Veterinary Medicine (CVM), 2001.
    • Guidance for Industry, Bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration center for Drug Evaluation And Research Center (CDER), Center for Veterinary Medicine (CVM), 2001. http://www/fda.gov/cder/guidance/index.htm.
  • 11
    • 77958505887 scopus 로고    scopus 로고
    • Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies
    • Bhatta R.S., Kumar D., Chhonker Y.S., Saxena A.K., Jain G.K. Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies. Biomed. Chromatogr. 2010, 24:1234-1239.
    • (2010) Biomed. Chromatogr. , vol.24 , pp. 1234-1239
    • Bhatta, R.S.1    Kumar, D.2    Chhonker, Y.S.3    Saxena, A.K.4    Jain, G.K.5
  • 12
    • 0032011562 scopus 로고    scopus 로고
    • Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations
    • Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 1998, 70:882-889.
    • (1998) Anal. Chem. , vol.70 , pp. 882-889
    • Matuszewski, B.K.1    Constanzer, M.L.2    Chavez-Eng, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.